Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cytochrome c-t

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cytochrome c-t in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(cytochrome c-t)		Trials
(cytochrome c-t)		Recent Studies (post-2010) (cytochrome c-t)
9,15618755211,809215,125

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, WF; Li, J; Liu, QM; Lu, YJ; Qiao, GF; Wang, ZG; Wu, L; Yang, BF; Zhang, ZR; Zhao, D1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cytochrome c-t

ArticleYear
PAF exerts a direct apoptotic effect on the rat H9c2 cardiomyocytes in Ca2+-dependent manner.
    International journal of cardiology, 2010, Aug-06, Volume: 143, Issue:1

    Topics: Animals; Apoptosis; Calcium; Caspase 3; Cell Line; Cell Survival; Chelating Agents; Cytochromes c; Egtazic Acid; MAP Kinase Signaling System; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Platelet Activating Factor; Rats

2010